(Q41061819)

English

Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Stout JE

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Arnold B

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Yu VL

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

37-43

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial chemotherapy for legionnaires' disease: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of azithromycin against clinical isolates of Legionella species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of monensin on the invasiveness and multiplication of Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics of Legionella pneumophila virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ototoxicity of Erythromycin in Patients with Renal Insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rote of the quinolones in the treatment of legionellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of the bactericidal activity of ampicillin/sulbactam and erythromycin against intracellular Legionella pneumophila.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoroquinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900174-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(97)00174-0

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41061819&oldid=1914230394"